5 Key Companies Hiring Scientific Sales Reps
As a medical or clinical professional, you possess a highly valuable skill set.
Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale and more continuous clinical data inside hospitals.
Danaher Corp. (NYSE:DHR) agreed to pay about $6.8 billion in cash for Beckman Coulter Inc. (NYSE:BEC), ending weeks of jockeying for the Brea, Calif.-based diagnostics player.